Skip to content
Home/Companies/MedTech/Xenios
XE

Xenios

MedTech·Germany·Exited 2016·Held 3yr

Xenios is a MedTech company, headquartered in Germany.

Entry
2013
Hold
3yr
Exit
2016
Est. EV
–

Who owns Xenios?

Xenios was owned by D11Z. Ventures through ZFHN Zukunftsfonds Heilbronn (D11Z. Ventures Evergreen) (2005 vintage) from 2013 to 2016, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

D11Z. Ventures
Investor
D11Z. Ventures
ZFHN Zukunftsfonds Heilbronn (D11Z. Ventures Evergreen) · 2005 · Evergreen

Key facts

HQGermany
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2016

More from ZFHN Zukunftsfonds Heilbronn (D11Z. Ventures Evergreen)

Other portfolio companies in the same fund.

CertHub
Active
HealthTechGermany· 2026
ConfidentialMind
Active
AI/MLFinland· 2026
deeplify
Active
SoftwareGermany· 2026
Alago
Active
SoftwareGermany· 2025
CERPRO
Active
SoftwareGermany· 2025
DaphOS
Active
HealthTechAustria· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Custom Surgical
Active
ZEISS VenturesGermany· 2026
DiappyMed
Active
Irdi Capital-InvestissementFrance· 2026
Hipp Technology Group
Active
Deutsche Beteiligungs AGGermany· 2026
Data refreshed weekly · Sourced from public filings